The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Abstract
BACKGROUND: We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. METHODS: A total of 1520 patients who had advanced heart failure (New York Heart Association class III or IV) due to ischemic or nonischemic cardiomyopathies and a QRS interval of at least 120 msec were randomly assigned in a 1:2:2 ratio to receive optimal pharmacologic therapy (diuretics, angiotensin-converting-enzyme inhibitors, beta-blockers, and spironolactone) alone or in combination with cardiac-resynchronization therapy with either a pacemaker or a pacemaker-defibrillator. The primary composite end point was the time to death from or hospitalization for any cause. RESULTS: As compared with optimal pharmacologic therapy alone, cardiac-resynchronization therapy with a pacemaker decreased the risk of the primary end point (hazard ratio, 0.81; P=0.014), as did cardiac-resynchronization therapy with a pacemaker-defibrillator (hazard ratio, 0.80; P=0.01). The risk of the combined end point of death from or hospitalization for heart failure was reduced by 34 percent in the pacemaker group (P<0.002) and by 40 percent in the pacemaker-defibrillator group (P<0.001 for the comparison with the pharmacologic-therapy group). A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker-defibrillator reduced the risk by 36 percent (P=0.003). CONCLUSIONS: In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While clinical improvements are generally achieved, six-month nonresponder rates have been reported to be as high as 32–43%11,13, which is partially attributed to anatomic constraints of lead positioning14.”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [13]
In the citing paper
“Device therapies (implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT], and CRT with an implantable defibrillator [CRT-D]) have similar efficacies and risks in patients with HFrEF with or without diabetes.[522][523][524][525]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [524]
Citations
Cites
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
CARDIAC RESYNCHRONIZATION IN CHRONIC HEART FAILURE
Braham, W. I. T. A., Isher, W. E. G. F., Mith, L. S., Elurgio, D. A. B. D., Eon, A. N. R. L., Oh, E., Ocovic, D. U. Z. K., Acker, M. G., Lavell, L. C., Ayes, D. A. L. H., et al. (2002) · Cited by 3,808
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Self-citationDiscrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Self-citationSt John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Auricchio, A., Stellbrink, C., Sack, S., Block, M., Vogt, J. Ü., Bakker, P., Huth, C., Schöndube, F., Wolfhard, U., Böcker, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01895-8 · Cited by 1,026
Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., McKenna, W., Fitzgerald, M., Deharo, J.-C., Alonso, C., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01932-0 · Cited by 973
Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121264 · Cited by 800
Cited by
Items 201–300 of 1,014
Givertz, M. M., Stevenson, L. W., Costanzo, M. R., Bourge, R. C., Bauman, J. G., Ginn, G., & Abraham, W. T. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.010 · Cited by 248
Lecoq, G., Leclercq, C., Leray, E., Crocq, C., Alonso, C., Place, C. D., Mabo, P., & Daubert, C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi146 · Cited by 246
Khairy, P., Van Hare, G. F., Balaji, S., Berul, C. I., Cecchin, F., Cohen, M. I., Daniels, C. J., Deal, B. J., Dearani, J. A., Groot, N. D., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.002 · Cited by 230
Gervais, R., Leclercq, C., Shankar, A., Jacobs, S., Eiskjær, H., Johannessen, A., Freemantle, N., Cleland, J. G. F., Tavazzi, L., & Daubert, C. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp074 · Cited by 243
Non-Responders to Cardiac Resynchronization Therapy - The Magnitude of the Problem and the Issues -
Auricchio, A., & Prinzen, F. W. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-1268 · Cited by 243
Bilchick, K. C., Dimaano, V., Wu, K. C., Helm, R. H., Weiss, R. G., Lima, J. A., Berger, R. D., Tomaselli, G. F., Bluemke, D. A., Halperin, H. R., et al. (2008) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.04.013 · Cited by 242
Self-citationA Comparison of Empiric to Physician-Tailored Programming of Implantable Cardioverter-Defibrillators
Wilkoff, B. L., Ousdigian, K. T., Sterns, L. D., Wang, Z. J., Wilson, R. D., & Morgan, J. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.037 · Cited by 242
Bilchick, K. C., Kamath, S., DiMarco, J. P., & Stukenborg, G. J. (2010) · Circulation · doi:10.1161/circulationaha.110.956011 · Cited by 240
ACC/AHA/HRS 2006 Key Data Elements and Definitions for Electrophysiological Studies and Procedures
Buxton, A. E., Calkins, H., Callans, D. J., DiMarco, J. P., Fisher, J. D., Leon Greene, H., Haines, D. E., Hayes, D. L., Heidenreich, P. A., Miller, J. M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.020 · Cited by 240
“In an effort to maintain consistency of definitions across the data standards documents, the committee also reviewed the ACC Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes (3) and the ACC/AHA Key Data Elements and Definitions for Measuring…”
MethodInfluentialReverse remodeling in heart failure—mechanisms and therapeutic opportunities
Koitabashi, N., & Kass, D. A. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.172 · Cited by 236
Self-citationEpstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Mark Estes, N. A., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.033 · Cited by 240
Heart failure with reduced ejection fraction
Bloom, M. W., Greenberg, B., Jaarsma, T., Januzzi, J. L., Lam, C. S. P., Maggioni, A. P., Trochu, J.-N., & Butler, J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.58 · Cited by 222
Upadhyay, G. A., Vijayaraman, P., Nayak, H. M., Verma, N., Dandamudi, G., Sharma, P. S., Saleem, M., Mandrola, J., Genovese, D., Oren, J. W., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.05.009 · Cited by 230
“COMPANION and CARE-HF were the initial landmark trials to demonstrate mortality benefit in patients undergoing CRT with BiV compared to medical therapy.(1,2) Improvements in LVEF have been inconsistently correlated with the magnitude of QRS narrowing,(23) although when dichotomized, increases in paced QRS duration(24)…”
The European cardiac resynchronization therapy survey
Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J. G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D. J., Brugada, J., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp359 · Cited by 233
“Table 6 reports the key characteristics of the patient cohorts in comparison with the patients included in this survey.(10,13,14) The REVERSE population as well as the population included in the recently concluded .”
ResultKadish, A., Nademanee, K., Volosin, K., Krueger, S., Neelagaru, S., Raval, N., Obel, O., Weiner, S., Wish, M., Carson, P., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.10.025 · Cited by 231
“OPTIMIZER lead fracture 3 (3) OPTIMIZER RV lead dislodgement 6 (6) IPG problem/change 2 (1) OPTIMIZER RA lead dislodgement 6 (5) OPTIMIZER pocket dehiscence/erosion 3 (3) OPTIMIZER pocket infection 2 (2) OPTIMIZER pocket stimulation 2 (2) Lead perforation 2 (2) OPTIMIZER pocket bleeding 1 Sensation due to CCM 2 (2) Ex…”
BackgroundSelf-citationPotential impact of optimal implementation of evidence-based heart failure therapies on mortality
Fonarow, G. C., Yancy, C. W., Hernandez, A. F., Peterson, E. D., Spertus, J. A., & Heidenreich, P. A. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.01.027 · Cited by 230
Goldenberg, I., Gillespie, J., Moss, A. J., Hall, W. J., Klein, H., McNitt, S., Brown, M. W., Cygankiewicz, I., Zareba, W., & and the Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II (2010) · Circulation · doi:10.1161/circulationaha.110.940148 · Cited by 230
Mode of Death in Advanced Heart Failure
Carson, P., Anand, I., O’Connor, C., Jaski, B., Steinberg, J., Lwin, A., Lindenfeld, J., Ghali, J., Barnet, J. H., Feldman, A. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.016 · Cited by 228
Self-citationRao, R. K., Kumar, U. N., Schafer, J., Viloria, E., De Lurgio, D., & Foster, E. (2007) · Circulation · doi:10.1161/circulationaha.106.634444 · Cited by 229
Cardiac Resynchronization Therapy
KASS, D. A. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.50136.x · Cited by 228
Self-citationThe Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J. C., & Erdmann, E. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.05.046 · Cited by 227
Moss, A. J., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, M., Foster, E., Greenberg, H. M., Hall, W. J., Higgins, S. L., Klein, H., et al. (2005) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2005.00073.x · Cited by 228
Predictors of Lack of Response to Resynchronization Therapy
Díaz-Infante, E., Mont, L., Leal, J., García-Bolao, I., Fernández-Lozano, I., Hernández-Madrid, A., Pérez-Castellano, N., Sitges, M., Pavón-Jiménez, R., Barba, J., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.02.009 · Cited by 226
Leclercq, C., Gadler, F., Kranig, W., Ellery, S., Gras, D., Lazarus, A., Clémenty, J., Boulogne, E., & Daubert, J.-C. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.074 · Cited by 226
Lindenfeld, J., Feldman, A. M., Saxon, L., Boehmer, J., Carson, P., Ghali, J. K., Anand, I., Singh, S., Steinberg, J. S., Jaski, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.629261 · Cited by 225
Self-citationLeyva, F., Foley, P. W., Chalil, S., Ratib, K., Smith, R. E., Prinzen, F., & Auricchio, A. (2011) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-13-29 · Cited by 225
St. John Sutton, M., Ghio, S., Plappert, T., Tavazzi, L., Scelsi, L., Daubert, C., Abraham, W. T., Gold, M. R., Hassager, C., Herre, J. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.818724 · Cited by 222
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
Zwanziger, J., Hall, W. J., Dick, A. W., Zhao, H., Mushlin, A. I., Hahn, R. M., Wang, H., Andrews, M. L., Mooney, C., Wang, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.032 · Cited by 221
Goldenberg, I., Moss, A. J., Hall, W. J., McNitt, S., Zareba, W., Andrews, M. L., & Cannom, D. S. (2006) · Circulation · doi:10.1161/circulationaha.105.577262 · Cited by 220
Reverse remodelling and myocardial recovery in heart failure
Kim, G. H., Uriel, N., & Burkhoff, D. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.139 · Cited by 220
Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator Surgery
BLOOM, H., HEEKE, B., LEON, A., MERA, F., DELURGIO, D., BESHAI, J., & LANGBERG, J. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00307.x · Cited by 220
Cleland, J., Freemantle, N., Ghio, S., Fruhwald, F., Shankar, A., Marijanowski, M., Verboven, Y., & Tavazzi, L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.036 · Cited by 221
Germano, J. J., Reynolds, M., Essebag, V., & Josephson, M. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.048 · Cited by 221
Predictors of response to cardiac resynchronization therapy (PROSPECT)—study design
Yu, C.-M., Abraham, W. T., Bax, J., Chung, E., Fedewa, M., Ghio, S., Leclercq, C., León, A. R., Merlino, J., Nihoyannopoulos, P., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.013 · Cited by 221
Zusterzeel, R., Selzman, K. A., Sanders, W. E., Caños, D. A., O’Callaghan, K. M., Carpenter, J. L., Piña, I. L., & Strauss, D. G. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.2717 · Cited by 214
KURTZ, S. M., OCHOA, J. A., LAU, E., SHKOLNIKOV, Y., PAVRI, B. B., FRISCH, D., & GREENSPON, A. J. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02670.x · Cited by 217
Optogenetics for in vivo cardiac pacing and resynchronization therapies
Nussinovitch, U., & Gepstein, L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3268 · Cited by 215
Barsheshet, A., Wang, P. J., Moss, A. J., Solomon, S. D., Al-Ahmad, A., McNitt, S., Foster, E., Huang, D. T., Klein, H. U., Zareba, W., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.041 · Cited by 216
Nanthakumar, K., Epstein, A. E., Kay, G. N., Plumb, V. J., & Lee, D. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.054 · Cited by 217
Vinther, M., Risum, N., Svendsen, J. H., Møgelvang, R., & Philbert, B. T. (2021) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2021.04.003 · Cited by 211
Adverse Remodeling and Reverse Remodeling After Myocardial Infarction
Bhatt, A. S., Ambrosy, A. P., & Velazquez, E. J. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0876-4 · Cited by 210
Strickberger, S. A., Conti, J., Daoud, E. G., Havranek, E., Mehra, M. R., Piña, I. L., & Young, J. (2005) · Circulation · doi:10.1161/01.cir.0000161276.09685.4a · Cited by 216
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.009 · Cited by 215
Self-citationBoriani, G., Da Costa, A., Quesada, A., Ricci, R. P., Favale, S., Boscolo, G., Clementy, N., Amori, V., Mangoni di S. Stefano, L., & Burri, H. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.626 · Cited by 213
Zhang, S., Zhou, X., & Gold, M. R. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.039 · Cited by 211
van Bommel, R. J., Bax, J. J., Abraham, W. T., Chung, E. S., Pires, L. A., Tavazzi, L., Zimetbaum, P. J., Gerritse, B., Kristiansen, N., & Ghio, S. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp368 · Cited by 212
“NYHA class IV, n (%) 2 (2) 6 (5) 3 (7) 0.”
Comorbidity of atrial fibrillation and heart failure
Ling, L.-H., Kistler, P. M., Kalman, J. M., Schilling, R. J., & Hunter, R. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.191 · Cited by 213
Rivero-Ayerza, M., Theuns, D. A. M. J., Garcia-Garcia, H. M., Boersma, E., Simoons, M., & Jordaens, L. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl203 · Cited by 211
“In two studies, ischaemic cardiomyopathy was the main aetiologic diagnosis.(10,11,23,24) Although most trials excluded patients with atrial fibrillation, one trial specifically evaluated the effects of CRT in this population.”
BackgroundGao, P., Yee, R., Gula, L., Krahn, A. D., Skanes, A., Leong-Sit, P., Klein, G. J., Stirrat, J., Fine, N., Pallaveshi, L., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.111.971549 · Cited by 212
2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure
Authors/Task Force Members, Dickstein, K., Vardas, P. E., Auricchio, A., Daubert, J.-C., Linde, C., McMurray, J., Ponikowski, P., Priori, S. G., Sutton, R., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq192 · Cited by 210
“In the COMPANION trial, CRT with or without an ICD, lowered the combined endpoint of all-cause mortality and rehospitalization for HF by 35–40%, mainly driven by the 76% lower rate of hospitalizations.(10) In CARE-HF, CRT-P lowered the proportion of unplanned hospitalizations for worsening HF by 52%, and the number of…”
BackgroundMethod2024 Clinical practice guidelines for Chronic heart failure
Galyavich, A. S., Tereshchenko, S. N., Uskach, T. M., Ageev, F. T., Aronov, D. M., Arutyunov, G. P., Begrambekova, Y. L., Belenkov, Y. N., Boytsov, S. A., Bubnova, M. G., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6162 · Cited by 204
Cardiac Resynchronization Therapy
Bax, J. J., Abraham, T., Barold, S. S., Breithardt, O. A., Fung, J. W. H., Garrigue, S., Gorcsan, J., Hayes, D. L., Kass, D. A., Knuuti, J., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.020 · Cited by 210
Self-citationJones, S. O., Eckart, R. E., Albert, C. M., & Epstein, L. M. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.01.009 · Cited by 216
Leyva, F., Taylor, R. J., Foley, P. W. X., Umar, F., Mulligan, L. J., Patel, K., Stegemann, B., Haddad, T., Smith, R. E. A., & Prasad, S. K. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.054 · Cited by 205
Henneman, M. M., Chen, J., Ypenburg, C., Dibbets, P., Bleeker, G. B., Boersma, E., Stokkel, M. P., van der Wall, E. E., Garcia, E. V., & Bax, J. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.063 · Cited by 205
Echocardiography in Heart Failure
Kirkpatrick, J. N., Vannan, M. A., Narula, J., & Lang, R. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.048 · Cited by 219
Hoppe, U. C., Casares, J. M., Eiskjær, H., Hagemann, A., Cleland, J. G. F., Freemantle, N., & Erdmann, E. (2006) · Circulation · doi:10.1161/circulationaha.106.614560 · Cited by 203
Wang, N. C. (2008) · JAMA · doi:10.1001/jama.299.22.2656 · Cited by 203
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
Nogami, A., Kurita, T., Abe, H., Ando, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 200
Sleep-Disordered Breathing and Cardiovascular Risk
Caples, S. M., Garcia-Touchard, A., & Somers, V. K. (2007) · Sleep · doi:10.1093/sleep/30.3.291 · Cited by 205
Aiba, T., Hesketh, G. G., Barth, A. S., Liu, T., Daya, S., Chakir, K., Dimaano, V. L., Abraham, T. P., O'Rourke, B., Akar, F. G., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.794834 · Cited by 200
“H ta u (m s) † Control DHF CRT (16)(10) (12)(10) (6) (7)0 100 200 300 400 500 A N T LT R A N T LT R A N T LT R † # ANT LTR Control DHF CRT F 0.”
InfluentialSelf-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E., Sato, K., Teramoto, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 191
Cardiac Resynchronization in Patients With Atrial Fibrillation
Upadhyay, G. A., Choudhry, N. K., Auricchio, A., Ruskin, J., & Singh, J. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.043 · Cited by 200
Hsich, E. M., & Piña, I. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.066 · Cited by 198
“At least 9 multicenter HF studies have been published since Petrie’s article (i.e., RALES [43], EPHE-SUS [44], A-HeFT [47], CHARM [37], ELITE II [Losartan Heart Failure Survival Study] [61], Val-HeFT [38], COPERNICUS [40], COMPANION [ 52 ], and CARE-HF [53]) and on average included 28% women.”
2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy
(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.11.003 · Cited by 196
Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?
Hawkins, N. M., Petrie, M. C., MacDonald, M. R., Hogg, K. J., & McMurray, J. J. V. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi826 · Cited by 196
Towbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H., Darrieux, F. C. C., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.09.019 · Cited by 195
Gold, M. R., Ip, J. H., Costantini, O., Poole, J. E., McNulty, S., Mark, D. B., Lee, K. L., & Bardy, G. H. (2008) · Circulation · doi:10.1161/circulationaha.107.748962 · Cited by 193
Bauer, A., Barthel, P., Schneider, R., Ulm, K., Müller, A., Joeinig, A., Stich, R., Kiviniemi, A., Hnatkova, K., Huikuri, H., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn540 · Cited by 194
Next-generation pacemakers: from small devices to biological pacemakers
Cingolani, E., Goldhaber, J. I., & Marbán, E. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.165 · Cited by 194
Freemantle, N., Tharmanathan, P., Calvert, M. J., Abraham, W. T., Ghosh, J., & Cleland, J. G. F. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.11.014 · Cited by 193
“COMPANION [18] 87% CONTAK-CD [6] 88% MIRACLE [17] 93% MIRACLE-ICD [5] 88%”
BackgroundMethodInfluentialHarkness, A., Ring, L., Augustine, D. X., Oxborough, D., Robinson, S., & Sharma, V. (2020) · Echo Research & Practice · doi:10.1530/erp-19-0050 · Cited by 191
“Furthermore, in UK practice, device therapy for heart failure, including CRT and ICD, are also indicated when the LVEF is 35% or below (38, 39, 40, 41).”
Anand, I. S., Carson, P., Galle, E., Song, R., Boehmer, J., Ghali, J. K., Jaski, B., Lindenfeld, J., O'Connor, C., Steinberg, J. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.793273 · Cited by 192
Self-citationRuwald, M. H., Solomon, S. D., Foster, E., Kutyifa, V., Ruwald, A.-C., Sherazi, S., McNitt, S., Jons, C., Moss, A. J., & Zareba, W. (2014) · Circulation · doi:10.1161/circulationaha.114.011283 · Cited by 189
FANTONI, C., KAWABATA, M., MASSARO, R., REGOLI, F., RAFFA, S., ARORA, V., SALERNO‐URIARTE, J. A., KLEIN, H. U., & AURICCHIO, A. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2005.40777.x · Cited by 191
Yao, G., Freemantle, N., Calvert, M. J., Bryan, S., Daubert, J.-C., & Cleland, J. G. F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl382 · Cited by 190
Adamson, P. B. (2009) · Current Heart Failure Reports · doi:10.1007/s11897-009-0039-z · Cited by 190
Bleeker, G. B., Mollema, S. A., Holman, E. R., Van De Veire, N., Ypenburg, C., Boersma, E., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2007) · Circulation · doi:10.1161/circulationaha.106.677005 · Cited by 190
“(3) Is LV resynchronization necessary for response to CRT, and if so, which extent of LV resynchronization is the best predictor of response to CRT?”
MethodCardiovascular Drug Development
Fordyce, C. B., Roe, M. T., Ahmad, T., Libby, P., Borer, J. S., Hiatt, W. R., Bristow, M. R., Packer, M., Wasserman, S. M., Braunstein, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.016 · Cited by 202
Self-citationGorcsan, J., Oyenuga, O., Habib, P. J., Tanaka, H., Adelstein, E. C., Hara, H., McNamara, D. M., & Saba, S. (2010) · Circulation · doi:10.1161/circulationaha.110.954768 · Cited by 189
Cardiac Sympathetic Imaging With mIBG in Heart Failure
Carrió, I., Cowie, M. R., Yamazaki, J., Udelson, J., & Camici, P. G. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.07.014 · Cited by 189
NERY, P. B., FERNANDES, R., NAIR, G. M., SUMNER, G. L., RIBAS, C. S., MENON, S. M. D., WANG, X., KRAHN, A. D., MORILLO, C. A., CONNOLLY, S. J., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01690.x · Cited by 188
Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF
Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., Heywood, J. T., McBride, M. L., Mehra, M. R., O'Connor, C. M., et al. (2008) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.772228 · Cited by 187
Okumura, N., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., Zile, M. R., Solomon, S. D., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020729 · Cited by 186
Healey, J. S., Hohnloser, S. H., Exner, D. V., Birnie, D. H., Parkash, R., Connolly, S. J., Krahn, A. D., Simpson, C. S., Thibault, B., Basta, M., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.968867 · Cited by 185
Linde, C., Gold, M. R., Abraham, W. T., St John Sutton, M., Ghio, S., Cerkvenik, J., Daubert, C., & on behalf of the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group (2013) · European Heart Journal · doi:10.1093/eurheartj/eht160 · Cited by 185
Three-Dimensional Mapping of Optimal Left Ventricular Pacing Site for Cardiac Resynchronization
Helm, R. H., Byrne, M., Helm, P. A., Daya, S. K., Osman, N. F., Tunin, R., Halperin, H. R., Berger, R. D., Kass, D. A., & Lardo, A. C. (2007) · Circulation · doi:10.1161/circulationaha.106.643718 · Cited by 184
Self-citationCurtis, J. P. (2009) · JAMA · doi:10.1001/jama.2009.547 · Cited by 184
Feldman, A. M., de Lissovoy, G., Bristow, M. R., Saxon, L. A., De Marco, T., Kass, D. A., Boehmer, J., Singh, S., Whellan, D. J., Carson, P., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.033 · Cited by 184
Self-citationThe Deleterious Consequences of Right Ventricular Apical Pacing: Time to Seek Alternate Site Pacing
MANOLIS, A. S. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00338.x · Cited by 183
Agricola, E., Ielasi, A., Oppizzi, M., Faggiano, P., Ferri, L., Calabrese, A., Vizzardi, E., Alfieri, O., & Margonato, A. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp051 · Cited by 178
Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes
Eng, G., Lee, B. W., Protas, L., Gagliardi, M., Brown, K., Kass, R. S., Keller, G., Robinson, R. B., & Vunjak-Novakovic, G. (2016) · Nature Communications · doi:10.1038/ncomms10312 · Cited by 176
Raphael, C. E., Whinnett, Z. I., Davies, J. E., Fontana, M., Ferenczi, E. A., Manisty, C. H., Mayet, J., & Francis, D. P. (2009) · Heart · doi:10.1136/hrt.2007.134973 · Cited by 178
Boriani, G., Müller, C. P., Seidl, K. H., Grove, R., Vogt, J., Danschel, W., Schuchert, A., Djiane, P., Biffi, M., Becker, T., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.08.019 · Cited by 177
Adelstein, E. C., Tanaka, H., Soman, P., Miske, G., Haberman, S. C., Saba, S. F., & Gorcsan, J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq389 · Cited by 176
Medical Therapy for Heart Failure Caused by Ischemic Heart Disease
Elgendy, I. Y., Mahtta, D., & Pepine, C. J. (2019) · Circulation Research · doi:10.1161/circresaha.118.313568 · Cited by 176
Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential
Martin, T. G., Juarros, M. A., & Leinwand, L. A. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00806-6 · Cited by 170
Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation
Gasparini, M., Leclercq, C., Lunati, M., Landolina, M., Auricchio, A., Santini, M., Boriani, G., Lamp, B., Proclemer, A., Curnis, A., et al. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.06.003 · Cited by 174
“This and other studies have shown that CRT also improves symptoms, exercise capacity, and quality of life, and induces LV reverse remodeling (5,6).”
BackgroundEchocardiography and Noninvasive Imaging in Cardiac Resynchronization Therapy
Bax, J. J., & Gorcsan, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.061 · Cited by 173
Miller, W. L., Hartman, K. A., Burritt, M. F., Grill, D. E., Rodeheffer, R. J., Burnett, J. C., & Jaffe, A. S. (2007) · Circulation · doi:10.1161/circulationaha.107.694562 · Cited by 174
Metadata
- Authors
- Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., DeVries, D. W., & Feldman, A. M.
- Affiliations
- University of Colorado Health (US)
- University of Southern California (US)
- Penn State Milton S. Hershey Medical Center (US)
- Bryan Health (US)
- Johns Hopkins Hospital (US)
- Veterans Health Administration (US)
- Pfizer (United States) (US)
- University of Wisconsin–Madison (US)
- Thomas Jefferson University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-20
- Volume
- 350
- Issue
- 21
- Pages
- 2140-2150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130907431
- Cited by
- 5,812
- References
- 22
- Citations by year
- 2026: 80 · 2025: 126 · 2024: 131 · 2023: 179 · 2022: 149 · 2021: 157 · 2020: 196 · 2019: 213 · 2018: 210 · 2017: 265 · 2016: 260 · 2015: 308 · 2014: 276 · 2013: 323 · 2012: 350
- FWCI
- 240.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Keywords
- cardiac resynchronization therapy, implantable cardioverter-defibrillator, advanced chronic heart failure, intraventricular conduction delay, heart failure hospitalization, mortality, cardiomyopathy, QRS duration, pharmacotherapy
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Chronic Disease, Combined Modality Therapy, Diuretics, Female, Heart Failure, Hospitalization, Humans, Male, Pacemaker, Artificial, Risk, Spironolactone, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.